Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2015 - 2018- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2015 - 2016
Yale School of MedicineClass of 2015
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2019 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 28 citationsUnraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell
NPJ Breast Cancer. 2018-08-02 - Immune Complex-Mediated Proliferative Glomerulonephritis Induced by Paclitaxel TreatmentBilal A. Siddiqui, Anna Greka, Mordecai Popovtzer, Helmut G. Rennke, Rinath Jeselsohn
Journal of Oncology Practice. 2016-11-15 - 19 citationsCell shape change and invagination of the cephalic furrow involves reorganization of F-actinAllison K. Spencer, Bilal A. Siddiqui, Jeffrey H. Thomas
Developmental Biology. 2015-06-15
Press Mentions
Cytokine Release Syndrome and Neurotoxicity After CAR T-cell TherapySeptember 20th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
